Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2021 Sep 8;9(11):3877–3884. doi: 10.1016/j.jaip.2021.09.003

Table 2:

Evidence for treatment and knowledge gaps in treating obesity, GERD, and OSA in asthma

Evidence for treatment Knowledge gaps
Obesity Weight loss
• Increased asthma quality of life, asthma control, improved lung function
Physical activity
• Increased asthma control
Improved diet quality
• Increased fruits and vegetables associated with decreased exacerbations
• Increased soluble fiber associated with increased asthma control
• Effective weight loss strategies
• Targeted pharmacologic therapies for metabolic abnormalities including increased HDL, L-citrulline supplementation, decreased triglycerides
• Gut microbiome manipulation
• Better understanding of immunomodulatory effects and possible treatment targeting adipokines
OSA CPAP for sleep apnea
• Improves asthma quality of life
• Improved asthma control and decreased daytime symptoms in observational studies
• Impact of CPAP treatment in preventing incident asthma
• Utility of routine screening for OSA among asthmatics
GERD Treating symptomatic GERD may improve
• Asthma quality of life
• Asthma symptoms
• Benefit of screening for and treating asymptomatic GERD
• Treatment duration
• Impact of medical vs surgical treatment for GERD